These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 34298701)

  • 1. Current Status and Future Perspectives about Molecular Biomarkers of Nasopharyngeal Carcinoma.
    Siak PY; Khoo AS; Leong CO; Hoh BP; Cheah SC
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasopharyngeal carcinoma: A review of current updates.
    Wu L; Li C; Pan L
    Exp Ther Med; 2018 Apr; 15(4):3687-3692. PubMed ID: 29556258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasopharyngeal carcinoma: molecular biomarker discovery and progress.
    Cho WC
    Mol Cancer; 2007 Jan; 6():1. PubMed ID: 17199893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic landscape of nasopharyngeal carcinoma.
    Dai W; Zheng H; Cheung AK; Lung ML
    Chin Clin Oncol; 2016 Apr; 5(2):16. PubMed ID: 27121876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma.
    Chan KC
    Chin J Cancer; 2014 Dec; 33(12):598-603. PubMed ID: 25418194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Diagnosis of Nasopharyngeal Carcinoma: Past and Future.
    Hsu CL; Chang YS; Li HP
    Biomed J; 2024 May; ():100748. PubMed ID: 38796105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker discovery of nasopharyngeal carcinoma by proteomics.
    Xiao L; Xiao T; Wang ZM; Cho WC; Xiao ZQ
    Expert Rev Proteomics; 2014 Apr; 11(2):215-25. PubMed ID: 24611579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omics-based identification of biomarkers for nasopharyngeal carcinoma.
    Janvilisri T
    Dis Markers; 2015; 2015():762128. PubMed ID: 25999660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma.
    Tan LP; Tan GW; Sivanesan VM; Goh SL; Ng XJ; Lim CS; Kim WR; Mohidin TBBM; Mohd Dali NS; Ong SH; Wong CY; Sawali H; Yap YY; Hassan F; Pua KC; Koay CE; Ng CC; Khoo AS;
    Int J Cancer; 2020 Apr; 146(8):2336-2347. PubMed ID: 31469434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma.
    Liu W; Li H; Sheng H; Liu X; Chi P; Wang X; Mao M
    Adv Ther; 2020 Oct; 37(10):4280-4290. PubMed ID: 32780356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives.
    Su ZY; Siak PY; Leong CO; Cheah SC
    Front Oncol; 2022; 12():840467. PubMed ID: 35311066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
    Tu C; Zeng Z; Qi P; Li X; Guo C; Xiong F; Xiang B; Zhou M; Liao Q; Yu J; Li Y; Li X; Li G; Xiong W
    Carcinogenesis; 2018 Dec; 39(12):1517-1528. PubMed ID: 30102338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma.
    Zhu QY; Zhao GX; Li Y; Talakatta G; Mai HQ; Le QT; Young LS; Zeng MS
    MedComm (2020); 2021 Jun; 2(2):175-206. PubMed ID: 34766141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
    Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
    Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs: potential diagnostic markers and therapeutic targets for EBV-associated nasopharyngeal carcinoma.
    He ML; Luo MX; Lin MC; Kung HF
    Biochim Biophys Acta; 2012 Jan; 1825(1):1-10. PubMed ID: 21958739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma.
    Liu L; Zuo L; Yang J; Xin S; Zhang J; Zhou J; Li G; Tang J; Lu J
    Cancer Med; 2019 Jun; 8(6):3142-3151. PubMed ID: 31063269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of microRNAs in nasopharyngeal carcinoma.
    Tan G; Tang X; Tang F
    Tumour Biol; 2015 Jan; 36(1):69-79. PubMed ID: 25427638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasopharyngeal carcinoma signaling pathway: an update on molecular biomarkers.
    Tulalamba W; Janvilisri T
    Int J Cell Biol; 2012; 2012():594681. PubMed ID: 22500174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radio-Susceptibility of Nasopharyngeal Carcinoma: Focus on Epstein- Barr Virus, MicroRNAs, Long Non-Coding RNAs and Circular RNAs.
    Lei F; Lei T; Huang Y; Yang M; Liao M; Huang W
    Curr Mol Pharmacol; 2020; 13(3):192-205. PubMed ID: 31880267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic susceptibility to the endemic form of NPC.
    Bei JX; Zuo XY; Liu WS; Guo YM; Zeng YX
    Chin Clin Oncol; 2016 Apr; 5(2):15. PubMed ID: 27121875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.